Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Tips for getting and paying for Epclusa, the newest hepatitis C treatment approved by the FDA.
Immunizations are safe and effective, so why doesn’t everyone protect their children?
While one in four people with hep C have advanced liver damage, many living with the virus aren’t even in regular medical care.
Editor-in-Chief of Hepatology, Medicine & Policy reflects on the need to bring health systems questions into the viral hepatitis discourse
The PROP UP study is evaluating patient-reported outcomes associated with the treatment of hepatitis C infection and benefits of viral cure.
Have you ever considered working with a health coach to help you reclaim your life back from hepatitis C?
An estimated 40 percent of all hepatitis B deaths worldwide occur in India each year.
Hepatitis B is the global pandemic no one talks about, yet one in three people worldwide has been infected.
The new once-daily, single-tablet, pangenotypic hepatitis C treatment has the potential to shake things up in the United States and abroad.
An op-ed about viral hepatitis funding compared to funding for Zika virus.
An interview with Dr. Mojca Matičič, Head of the National Viral Hepatitis Expert Group in Slovenia.
An op-ed on what occurs if we disregard the health and welfare of tens of thousands of refugees.
An interview with Charles Gore, chief executive and cofounder of The Hepatitis C Trust and founder of the World Hepatitis Alliance.
Experts believe a cure for hepatitis B will also soon be developed.
For those with advanced liver disease, treatment for hepatitis C is more complex. But the new treatments offer considerable hope as well.
An interview with Achim Kautz, special consultant of the European Liver Patients Association and director of the German Liver Help Project